Open AccessL-carnitine supplementation improves hematological pattern in patients affected by HCV treated with Peg interferon-α 2b plus ribavirin
Author(s) -
Michele Malaguarnera,
Marco Vacante,
Maria Giordano,
Massimo Motta,
Gaetano Bertino,
Manuela Pennisi,
Sergio Neri,
Mariano Malaguarnera,
Giovanni Li Volti,
Fabio Galvano
Publication year - 2011
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v17.i39.4414
Subject(s) - ribavirin , medicine , gastroenterology , white blood cell , leukopenia , viremia , anemia , carnitine , hepatitis c virus , hemoglobin , immunology , chemotherapy , virus
To evaluate the efficacy of L-carnitine on alleviating anemia, thrombocytopenia and leukopenia, and minimizing dose reductions in patients with chronic hepatitis C virus (HCV) in treatment with Interferon α (IFN-α) plus ribavirin.